This is the last of the three-part podcast series, Keeping up with the Chemos, on tisotumab vedotin. Our multidisciplinary panel discusses the challenges with patient monitoring while on tisotumab vedotin. Additional commentary includes personal clinical experiences and lessons learned, when to dose adjust and hold, or even when to discontinue tisotumab vedotin. Once again, the session ends with take home points for patient monitoring while on tisotumab vedotin. 

Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD 
Judith Smith, PharmD 

Speakers:
Julia Canestraro, OD, FAAO
Shannon Westin, MD 
Erin Hickey Zacholski, PharmD

Keywords: tisotumab vedotin, Keeping up with the Chemos, chemotherapy orders, the drug preparation and administration of tisotumab vedotin, toxicity prevention interventions